New Non-opioid Analgesic, New drug for Alzheimer's disease and Multiple sclerosis
Our experimental drug, ELB00824, is the next generation of non-opioid painkiller for Neuropathic Pain (NP), and new therapeutic for Alzheimer's Disease (AD) and Multiple Sclerosis. Elixiria intends to apply for an Orphan Drug Designation for ELB00824 for Trigeminal Neuralgia. It is a topical New Chemical Entity (NCE), offering extraordinary efficacy and a high safety profile as per results in animal models of NP and AD. So far, in the CNS therapeutic areas around the world, ELB00824 is the only highly nerve permeable PPARgamma-targeting drug, and the only disease modifying treatment. Other painkillers and AD drug merely provide symptomatic treatments
Member count: 1-10